Fox Chase Cancer Center is a National Cancer Institute-designated Comprehensive Cancer Center research facility and hospital located in the Fox Chase section of Philadelphia, Pennsylvania, United States. The main facilities of the center are located on property adjoining Burholme Park.

During the past decade, Fox Chase Cancer Center conducted 388 clinical trials. In the 10-year time frame, 388 clinical trials started and 347 clinical trials were completed, i.e. on average, 89.4% percent of trials that started reached the finish line to date. In the past 5 years, 110 clinical trials started and 171 clinical trials were completed. i.e. 155.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fox Chase Cancer Center" #1 sponsor was "Fox Chase Cancer Center" with 169 trials, followed by "National Cancer Institute (NCI)" with 134 trials sponsored, "Radiation Therapy Oncology Group" with 74 trials sponsored, "Gynecologic Oncology Group" with 63 trials sponsored and "Eastern Cooperative Oncology Group" with 63 trials sponsored. Other sponsors include 614 different institutions and companies that sponsored additional 263 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fox Chase Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 421 trials as a collaborator, "NRG Oncology" with 57 trials as a collaborator, "Merck Sharp & Dohme LLC" with 28 trials as a collaborator, "Eastern Cooperative Oncology Group" with 19 trials as a collaborator and "Bristol-Myers Squibb" with 17 trials as a collaborator. Other collaborators include 436 different institutions and companies that were collaborators in the rest 224 trials.

According to Clinical.Site data, the most researched conditions in "Fox Chase Cancer Center" are "Prostate Cancer" (64 trials), "Breast Cancer" (51 trials), "Lung Cancer" (51 trials), "Head and Neck Cancer" (46 trials) and "Ovarian Cancer" (43 trials). Many other conditions were trialed in "Fox Chase Cancer Center" in a lesser frequency.

Most popular intervention types in "Fox Chase Cancer Center" are "Drug" (852 trials), "Biological" (248 trials), "Other" (240 trials), "Radiation" (182 trials) and "Procedure" (167 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (96 trials), "radiation therapy" (66 trials), "paclitaxel" (58 trials), "Paclitaxel" (56 trials) and "cisplatin" (55 trials). Other intervention names were less common.

The vast majority of trials in "Fox Chase Cancer Center" are 874 trials for "All" genders, 171 trials for "Female" genders and 73 trials for "Male" genders.

Currently, there are NaN active trials in "Fox Chase Cancer Center". undefined are not yet recruiting, 141 are recruiting, 192 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 613 completed trials in Fox Chase Cancer Center, 6 suspended trials, and 124 terminated clinical trials to date.

Out of the total trials that were conducted in Fox Chase Cancer Center, 266 "Phase 1" clinical trials were conducted, 538 "Phase 2" clinical trials and 284 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 92 trials that are defined as “Not Applicable".

Fox Chase Cancer Center has several departments that took part in Clinical trials: "Fox Chase Cancer Center - East Norriton Hospital Outpatient Center" - 22 trials, "Fox Chase Cancer Center Buckingham" - 21 trials, "Fox Chase Cancer Center" - 8 trials, "Fox Chase Cancer Center Extramural Research Program" - 4 trials, "Fox Chase Cancer Center; Hematology/Oncology" - 3 trials, "Fox Chase Cancer Center 333 Cottman Avenue" - 2 trials